Financial News
Articles published by Pacira BioSciences

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings
November 04, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
October 30, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
October 21, 2024
From Pacira BioSciences
Via GlobeNewswire


Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
October 03, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX


Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 09, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX















Pacira to Report 2023 Financial Results on Thursday February 29, 2024
February 22, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX





Pacira Appoints Frank D. Lee as Chief Executive Officer
December 21, 2023
From Pacira BioSciences
Via GlobeNewswire

Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
November 10, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
November 07, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX

Pacira BioSciences Reports Third Quarter 2023 Financial Results
November 02, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.